+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Fenoverine Market by Product Type (Capsules, Tablets), Application (Abdominal Spasms, Stomach Spasms), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977780
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fenoverine Market grew from USD 226.54 million in 2023 to USD 237.71 million in 2024. It is expected to continue growing at a CAGR of 5.02%, reaching USD 319.32 million by 2030.

It works by helping to relax the smooth muscles of the gastrointestinal tract, which can alleviate symptoms, including abdominal pain, bloating, and discomfort often associated with conditions including irritable bowel syndrome and similar gastrointestinal ailments. Fenoverine is classified as a spasmolytic agent, which helps reduce spasms or involuntary muscle contractions in the digestive system. This action helps improve the comfort and digestive function of patients experiencing these issues. The rising global incidence of gastrointestinal disorders, including irritable bowel syndrome and spasmodic pain, and the steady flow of investment into developing safer and more effective formulations drive the market growth. However, the availability of alternate therapeutic technologies and medicines coupled with significant side effects for fenoverine can deter the adoption of the market. Nevertheless, developing improved drug delivery systems, such as extended-release capsules or soluble tablets, and increasing collaborations between pharmaceutical companies and academic institutions are anticipated to spur innovation and efficiency in the R&D processes for fenoverine, further creating market growth opportunities.

Regional Insights

The market for fenoverine in the Americas shows growth, primarily due to the growing awareness of irritable bowel syndrome (IBS) and similar gastrointestinal conditions for which fenoverine is prescribed. In these regions, there is high access to healthcare services, and patients generally exhibit high compliance with prescribed treatments. Recent investments have been directed toward improving the formulation and minimizing possible side effects of the drug. The European market for fenoverine presents a varied landscape, with considerable differences in market dynamics from one country to another, influenced by differing healthcare policies and regulations. Recently, there has been significant investment in research into gastrointestinal diseases in Europe, partly funded by the EU's health programs. This has facilitated better understanding and awareness, potentially increasing the need for treatments, including fenoverine. Patent activity in the EU primarily revolves around improving the pharmacological profiles of existing drugs and reducing the incidence of drug-induced side effects. In the Middle East and Africa, the market for fenoverine is growing with recent initiatives aimed at boosting healthcare facilities, coupled with increasing investments from multinational pharmaceutical companies. The Asia-Pacific region is showcasing rapid growth in the fenoverine market, propelled by rising incidences of lifestyle-induced gastrointestinal disorders, particularly in urban areas. Expanding healthcare infrastructure and governmental initiatives to improve the population's general health across APAC are significant drivers. Furthermore, advanced medical research and pharmaceutical innovations have seen several new patents filed for fenoverine, focusing on enhanced delivery mechanisms and combination therapies.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Fenoverine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Growing awareness and the need for effective gastrointestinal treatments
  • Expanding healthcare infrastructure and governmental initiatives

Market Restraints

  • Limitations and side effects associated with fenoverine

Market Opportunities

  • Advancements in drug delivery systems for fenoverine
  • Collaborative research and development initiatives

Market Challenges

  • Presence of counterfeit drugs, along with the availability of alternate therapeutic technologies and medicines

Market Segmentation Analysis

  • Product Type: Increasing preference for the fenoverine capsule owing to their minimal taste and odor
  • End-Use: Evolving usage of fenoverine in home healthcare settings

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Fenoverine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Fenoverine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Burkina Faso Opens New Pharmaceutical Plant to Boost Health Independence and Economic Growth

Burkina Faso inaugurated its pharmaceutical manufacturing plant to produce low-cost generic drugs, primarily targeting the local supply of essential medications. Under the entity Propharm, Burkinabe pharmacists reported that the new facility initially focused on medications such as paracetamol, the antispasmodic agent phloroglucinol, and treatments for diarrhea, including oral rehydration salts and zinc. Situated on a 1.5-hectare site near Ouagadougou in Komsilga, this plant represents a critical step toward self-reliance, addressing the frequent shortages and high costs of drugs exacerbated by the heavy reliance on imports

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Fenoverine Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Fenoverine Market, highlighting leading vendors and their innovative profiles. These include American Custom Chemicals Corporation, Dayang Chem (Hangzhou) Co.,Ltd., Enomark, JoinHub Pharma, LGC Limited, Mars Therapeutics Private Limited, Medical Isotopes, Inc., Micro Labs Limited, Sri Krishna Pharmaceuticals Ltd., Synmosa Biopharma Corporation, and Taj Pharmaceuticals Ltd..

Market Segmentation & Coverage

This research report categorizes the Fenoverine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type

  • Capsules
  • Tablets

Application

  • Abdominal Spasms
  • Stomach Spasms

End-Use

  • Home Healthcare Settings
  • Hospitals & Clinics

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness and the need for effective gastrointestinal treatments
5.1.1.2. Expanding healthcare infrastructure and governmental initiatives
5.1.2. Restraints
5.1.2.1. Limitations and side effects associated with fenoverine
5.1.3. Opportunities
5.1.3.1. Advancements in drug delivery systems for fenoverine
5.1.3.2. Collaborative research and development initiatives
5.1.4. Challenges
5.1.4.1. Presence of counterfeit drugs, along with the availability of alternate therapeutic technologies and medicines
5.2. Market Segmentation Analysis
5.2.1. Product Type: Increasing preference for the fenoverine capsule owing to their minimal taste and odor
5.2.2. End-Use: Evolving usage of fenoverine in home healthcare settings
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Fenoverine Market, by Product Type
6.1. Introduction
6.2. Capsules
6.3. Tablets
7. Fenoverine Market, by Application
7.1. Introduction
7.2. Abdominal Spasms
7.3. Stomach Spasms
8. Fenoverine Market, by End-Use
8.1. Introduction
8.2. Home Healthcare Settings
8.3. Hospitals & Clinics
9. Americas Fenoverine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Fenoverine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Fenoverine Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Burkina Faso Opens New Pharmaceutical Plant to Boost Health Independence and Economic Growth
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. FENOVERINE MARKET RESEARCH PROCESS
FIGURE 2. FENOVERINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL FENOVERINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. FENOVERINE MARKET DYNAMICS
FIGURE 7. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. FENOVERINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. FENOVERINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. FENOVERINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL FENOVERINE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL FENOVERINE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL FENOVERINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL FENOVERINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL FENOVERINE MARKET SIZE, BY CAPSULES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL FENOVERINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL FENOVERINE MARKET SIZE, BY TABLETS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL FENOVERINE MARKET SIZE, BY ABDOMINAL SPASMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL FENOVERINE MARKET SIZE, BY ABDOMINAL SPASMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL FENOVERINE MARKET SIZE, BY STOMACH SPASMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL FENOVERINE MARKET SIZE, BY STOMACH SPASMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL FENOVERINE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL FENOVERINE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL FENOVERINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL FENOVERINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. AMERICAS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 26. AMERICAS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 27. AMERICAS FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 28. AMERICAS FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS FENOVERINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 33. ARGENTINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 34. ARGENTINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 35. ARGENTINA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 36. ARGENTINA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 39. BRAZIL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 40. BRAZIL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 41. BRAZIL FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. BRAZIL FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 45. CANADA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 46. CANADA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 47. CANADA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. CANADA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. CANADA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 50. CANADA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 51. MEXICO FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 52. MEXICO FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 53. MEXICO FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. MEXICO FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. MEXICO FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 56. MEXICO FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 57. UNITED STATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 58. UNITED STATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 59. UNITED STATES FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. UNITED STATES FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES FENOVERINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 66. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC FENOVERINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 73. AUSTRALIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 74. AUSTRALIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 75. AUSTRALIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. AUSTRALIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 79. CHINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 80. CHINA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 81. CHINA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. CHINA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. CHINA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 84. CHINA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 85. INDIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 86. INDIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 87. INDIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. INDIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. INDIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 90. INDIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 91. INDONESIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 92. INDONESIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 93. INDONESIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. INDONESIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 97. JAPAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 98. JAPAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 99. JAPAN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. JAPAN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. JAPAN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 102. JAPAN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 103. MALAYSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 104. MALAYSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 105. MALAYSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. MALAYSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 109. PHILIPPINES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 110. PHILIPPINES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 111. PHILIPPINES FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. PHILIPPINES FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 115. SINGAPORE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 116. SINGAPORE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 117. SINGAPORE FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. SINGAPORE FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 121. SOUTH KOREA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 122. SOUTH KOREA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 123. SOUTH KOREA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. SOUTH KOREA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 127. TAIWAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 128. TAIWAN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 129. TAIWAN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. TAIWAN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 133. THAILAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 134. THAILAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 135. THAILAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. THAILAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. THAILAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 138. THAILAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 139. VIETNAM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 140. VIETNAM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 141. VIETNAM FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. VIETNAM FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA FENOVERINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 153. DENMARK FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 154. DENMARK FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 155. DENMARK FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. DENMARK FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. DENMARK FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 158. DENMARK FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 159. EGYPT FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 160. EGYPT FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 161. EGYPT FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. EGYPT FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. EGYPT FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 164. EGYPT FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 165. FINLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 166. FINLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 167. FINLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. FINLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. FINLAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 170. FINLAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 171. FRANCE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 172. FRANCE FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 173. FRANCE FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. FRANCE FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. FRANCE FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 176. FRANCE FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 177. GERMANY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 178. GERMANY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 179. GERMANY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. GERMANY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. GERMANY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 182. GERMANY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 183. ISRAEL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 184. ISRAEL FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 185. ISRAEL FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. ISRAEL FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 189. ITALY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 190. ITALY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 191. ITALY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. ITALY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. ITALY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 194. ITALY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 195. NETHERLANDS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 196. NETHERLANDS FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 197. NETHERLANDS FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. NETHERLANDS FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 201. NIGERIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 202. NIGERIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 203. NIGERIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. NIGERIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 207. NORWAY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 208. NORWAY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 209. NORWAY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. NORWAY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. NORWAY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 212. NORWAY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 213. POLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 214. POLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 215. POLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. POLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. POLAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 218. POLAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 219. QATAR FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 220. QATAR FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 221. QATAR FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. QATAR FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. QATAR FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 224. QATAR FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 225. RUSSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 226. RUSSIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 227. RUSSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. RUSSIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 232. SAUDI ARABIA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. SAUDI ARABIA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 238. SOUTH AFRICA FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. SOUTH AFRICA FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 243. SPAIN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 244. SPAIN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 245. SPAIN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. SPAIN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. SPAIN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 248. SPAIN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 249. SWEDEN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 250. SWEDEN FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 251. SWEDEN FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SWEDEN FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 255. SWITZERLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 256. SWITZERLAND FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 257. SWITZERLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. SWITZERLAND FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 261. TURKEY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 262. TURKEY FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 263. TURKEY FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. TURKEY FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. TURKEY FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 266. TURKEY FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 274. UNITED KINGDOM FENOVERINE MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM FENOVERINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. UNITED KINGDOM FENOVERINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM FENOVERINE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM FENOVERINE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 279. FENOVERINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 280. FENOVERINE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • American Custom Chemicals Corporation
  • Dayang Chem (Hangzhou) Co.,Ltd.
  • Enomark
  • JoinHub Pharma
  • LGC Limited
  • Mars Therapeutics Private Limited
  • Medical Isotopes, Inc.
  • Micro Labs Limited
  • Sri Krishna Pharmaceuticals Ltd.
  • Synmosa Biopharma Corporation
  • Taj Pharmaceuticals Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 237.71 Million
Forecasted Market Value ( USD ) by 2030 $ 319.32 Million
Compound Annual Growth Rate5.0%
Regions CoveredGlobal

Related Topics

Related Reports

Fenoverine (CAS 37561-27-6) Global Market Research Report 2024 - Product Image

Fenoverine (CAS 37561-27-6) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Global Alvimopan Market by Therapeutic Application (Opioid-Induced Constipation, Postoperative Ileus Prevention), End-User (Hospitals, Surgical Centers) - Forecast 2024-2030 - Product Image

Global Alvimopan Market by Therapeutic Application (Opioid-Induced Constipation, Postoperative Ileus Prevention), End-User (Hospitals, Surgical Centers) - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Global Cholestyramine Market by Grade (Industrial Grade, Pharmaceutical Grade), Purity (High-Purity, Standard-Purity), End Use, Application - Forecast 2024-2030 - Product Image

Global Cholestyramine Market by Grade (Industrial Grade, Pharmaceutical Grade), Purity (High-Purity, Standard-Purity), End Use, Application - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Global Antiemetics Drugs Market Size, Share & Trends Analysis Report by Drug Type (Serotonin-receptor Antagonists, Dopamine Receptor Antagonists), Application, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Antiemetics Drugs Market Size, Share & Trends Analysis Report by Drug Type (Serotonin-receptor Antagonists, Dopamine Receptor Antagonists), Application, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Global Glucagon-Like Peptide 1 (GLP-1) Agonist market (2024 Edition): Analysis by Type, End-Use (Type 2 Diabetes, NASH, Obesity), By Distribution Channel, By Route of Administration, By Region, By Country: Market Insights and Forecast (2020-2030) - Product Image

Global Glucagon-Like Peptide 1 (GLP-1) Agonist market (2024 Edition): Analysis by Type, End-Use (Type 2 Diabetes, NASH, Obesity), By Distribution Channel, By Route of Administration, By Region, By Country: Market Insights and Forecast (2020-2030)

  • Report
  • 250 Pages
  • Global
From

About the Fenoverine Market

Fenoverine is a drug used to treat gastrointestinal disorders, such as irritable bowel syndrome (IBS) and functional dyspepsia. It is a muscarinic receptor antagonist, meaning it blocks the action of the neurotransmitter acetylcholine, which is involved in the regulation of gastrointestinal motility. Fenoverine is available in both oral and rectal formulations, and is generally well tolerated with few side effects. The market for fenoverine is growing, as it is increasingly being used to treat a variety of gastrointestinal disorders. It is becoming increasingly popular due to its efficacy and safety profile, as well as its availability in both oral and rectal formulations. Additionally, its low cost and ease of use make it an attractive option for many patients. Some companies in the fenoverine market include Novartis, Merck, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.